Endovascular Treatment of Infective Endocarditis-Related Acute Large Vessel Occlusion Stroke

J Stroke Cerebrovasc Dis. 2021 Jun;30(6):105775. doi: 10.1016/j.jstrokecerebrovasdis.2021.105775. Epub 2021 Apr 8.

Abstract

Objectives: Embolic stroke is a frequent complication of infective endocarditis yet lacks acute treatment as intravenous thrombolysis should be avoided due to high risk of intracerebral hemorrhage. Mechanical thrombectomy for large vessel occlusion may be a promising treatment but there is limited data on safety outcomes in infective endocarditis.

Materials and methods: In this multi-center retrospective case series, we reviewed data from patients with infective endocarditis-related large vessel occlusion who underwent mechanical thrombectomy in 9 US hospitals.

Results: We identified 15 patients at 9 hospitals. A minority presented with signs suggesting infection (2 patients (14%) had fever, 7 (47%) were tachycardic, 2 (13%) were hypotensive, and 8 (53%) had leukocytosis). The median National Institute of Health Stroke Score decreased from 19 (range 9-25) at presentation to 7 post-thrombectomy (range 0-22, median best score post-thrombectomy), and the median modified Rankin Scale on or after discharge for survivors was 3 (range 0-6). Approximately 57% of patients had a modified Rankin Scale between 0 and 3 on or after discharge. Hemorrhagic transformation was observed in 7/15 (47%). The mechanical thrombectomy group had 2/9 petechial hemorrhagic transformation (22%), compared to 4/6 parenchymal hematomas (67%) in the tissue plasminogen activator + mechanical thrombectomy group.

Conclusions: Our findings suggest that patients with large vessel occlusion due to infective endocarditis may not present with overt signs of infection. Mechanical thrombectomy may be an effective treatment in this patient population for whom intravenous thrombolysis should be avoided.

Keywords: Infective endocarditis; Large-vessel occlusion; Stroke; Thrombectomy.

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Combined Modality Therapy
  • Disability Evaluation
  • Embolic Stroke / diagnosis
  • Embolic Stroke / etiology
  • Embolic Stroke / physiopathology
  • Embolic Stroke / therapy*
  • Endocarditis / complications*
  • Endocarditis / diagnosis
  • Endovascular Procedures* / adverse effects
  • Female
  • Functional Status
  • Humans
  • Intracranial Hemorrhages / etiology
  • Male
  • Middle Aged
  • Recovery of Function
  • Retrospective Studies
  • Thrombectomy* / adverse effects
  • Thrombolytic Therapy / adverse effects
  • Time Factors
  • Treatment Outcome
  • United States